IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enzon Pharmaceuticals Inc

CUSIP: 29390410 | 4 institutional holders

Quarters

Q1 2016Q4 2015Q3 2015Q2 2015Q1 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2016

Arrowstreet Capital, Limited Partnership115,380
0.0% of portfolio›$54
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
115,380$540.0%GARPHighBoston, MA2016-05-16